Abstract
In spite of the stigma that surrounds AIDS and the discrimination that has been endured by most people carrying the virus, amazing medical advances have been made in treating this disease. By 2010, there were approximately 30 FDA-approved antiretroviral medications to treat HIV infection.1 Many of these are combination drugs that facilitate compliance in taking a large number of pills and in turn increase survival rates. Before these antiretrovirals, the median survival of a person with AIDS was one and a half years, but today the median survival has increased to 14.9 years.2
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Notes
Susan M. Chambre, Fighting for Our Lives: New York’s AIDS Community and the Politics of Disease (New Brunswick, New Jersey, and London: Rutgers University Press, 2006), pp. 184–186.
Anne Katz, “Gay and Lesbian Patients with Cancer,” Oncology Nursing Forum, 36, no. 2, March 2009, p. 205.
Copyright information
© 2012 Gina M. Bright
About this chapter
Cite this chapter
Bright, G.M. (2012). Conclusions: The Legacy of Plague-Making. In: Plague-Making and the AIDS Epidemic: A Story of Discrimination. Palgrave Macmillan, New York. https://doi.org/10.1057/9781137011220_11
Download citation
DOI: https://doi.org/10.1057/9781137011220_11
Publisher Name: Palgrave Macmillan, New York
Print ISBN: 978-1-349-34336-2
Online ISBN: 978-1-137-01122-0
eBook Packages: Palgrave Political & Intern. Studies CollectionPolitical Science and International Studies (R0)